fda ruling on tirzepatide today says the weight-loss drug shortage is over FDA declares Mounjaro, Zepbound shortage

It is the difference between accurate dosing and guessing

Not every patient reaches the highest dosemany achieve their weight-loss and health goals at intermediate doses like 7.5 or 10 mg

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial The Lancet

Worldwide, theres an estimated 830 million people living with diabetes and 1 billion people living with obesity

Insulin secretion improves, leading to better blood sugar control and reduced fat storage

Additionally, vascular endothelium becomes less effective at regulating blood flow and preventing clot formation, leading to endothelial dysfunction, increasing the risk of atherosclerosis, thrombosis, and other vascular diseases